CADue in 11 days · Sep 30, 2026
Strategic Growth Council
The TCC Program furthers the purposes of AB 32 (Nunez, 2006) and AB 2722 (Burke, 2016) by funding projects that reduce greenhouse gas emissions (GHG) through the development and implementation of neighborhood-level transformative climate community plans that include multiple coordinated GHG emissions reduction projects that provide local economic, environmental, and health benefits to disadvantaged communities.
The Transformative Climate Communities (TCC) Program, established by AB 2722 (Burke, 2016), invests in community-led climate resilience projects in the state’s most overburdened communities. The program objectives are to reduce greenhouse gas emissions, improve public health and the environment, and support economic opportunity and shared prosperity. TCC’s unique, place-based strategy for reducing greenhouse gas emissions is designed to catalyze collective impact through a combination of community-driven climate projects in a single neighborhood. TCC Implementation Grants fund neighborhood-scale applications that include multiple, coordinated projects to reduce greenhouse gas emissions and deliver broader community benefits. These grants support climate resilience projects and infrastructure that respond to community-identified needs in Tribal, disadvantaged, and low-income communities. TCC Planning Grants and Project Development Grants support planning and pre-development activities to prepare for future funding opportunities and advance community-led goals and projects. Please see separate Grants Portal entries for information on Planning Grants and Project Development Grants. Implementation project examples include, but are not limited to: · Equitable housing and neighborhood development · Land acquisition for neighborhood stabilization · Transit access and mobility · Solar installation and energy efficiency · Water efficiency and resiliency · Recycling, composting, and waste reduction · Health equity and well-being · Indoor air quality · Community microgrids · Brownfield redevelopment · Community resilience centers At least 2 Co-Applicants are required. All Lead and Co-Applicants, with local residents and leadership, must form a Collaborative Governance Structure to develop a shared vision of transformation for their community. This may include: · Community-based organizations · Local governments · Nonprofit organizations · Philanthropic organizations and foundations · Faith-based organizations · Coalitions or associations of nonprofits · Community development finance institutions · Community development corporations · Joint powers authorities · California Native American Tribes Applicants from Tribal Communities, Tribally-owned non-profits, and with Project Areas in Disadvantaged Unincorporated Communities are prioritized for Application Technical Assistance. July 31, 2026, is the priority deadline to request Application Technical Assistance via the TA Application Request Form. Application TA services may be available to additional applicants depending on funding availability and TA provider capacity after the July 31st deadline. Applicants must submit a Pre-Proposal by 11:59 p.m. PST on June 30, 2026. Though submission of a Pre-Proposal is required for all Implementation Grant Applicants, the content of the proposal will not affect evaluation of the final application or disqualify Applicants from submitting an application.
Amount not specifiedOfficial notice ↗ CADue in 11 days · Sep 30, 2026
Department of Forestry and Fire Protection
CAL FIRE’s Forest Legacy Program funds landscape-scale conservation projects intended to conserve working forests and working forested landscapes. This solicitation aims to increase organizational capacity for eligible applicants and support the development of high-quality forest conservation projects. Funding for this solicitation is limited to the preparation and development of potential future projects.
Eligible Activities: Future Projects - Funding for Forest Legacy Grant Due Diligence: Grant funds can be requested to prepare and develop future working forest conservation easement or fee acquisition projects for completion under a Federal OR State Grant. These will be referred to as “Future Projects” throughout the grant guide. The actual transactions for these Future Projects will need to be prepared and submitted for Federal or State Forest Legacy Funding at a future date, for either Forest Legacy solicitations, or solicitations to other federal or state conservation programs. Projects receiving funding under this grant line item are not guaranteed Federal or State Forest Legacy funding for projects in the future. Future Projects can include costs for preparing the following: Market analysis or restricted use appraisal for Future Projects in development; Preliminary title report and any associated documents listed in that report (deed, easements, MOUs), as well as the costs to remove exceptions; Minerals Remoteness Report or statement; Land survey with acreage and Description verification; Mapping products / GIS; Development and negotiation of Conservation Easement (CE) Deed (if not acquiring in fee); CE Baseline Document (if not acquiring in fee); Phase 1 Environmental Assessment; Forest Management Plan, Agricultural Management Plan and/or Grazing Management Plan; Soliciting and developing potential FLP projects; Organizational staff time associated with preparation of the above mentioned documents or general work towards completion of the project; Salaries, fringe benefits, travel and supplies that directly support the FLP; Facilitating the donation of lands or interests of lands into the FLP. Eligible Applicants: These can include, but are not limited to; nonprofits, land trusts, and conservation organizations. This program will not grant funding to a private person, business or other private entity to hold ownership of these interests (fee title or CE) using State funds. Any applicant not eligible to hold a Land Conservation Easement shall specify the intended Land Conservation Easement organization within the application. Eligible Lands are: Land that can support 10-percent native tree cover of any species, including hardwoods, under natural conditions, and has a minimum of 75 percent forestland or a documented plan that includes sufficient landowner capacity to reforest to at least 75 percent forestland. The land should allow for management of one or more forest resources, including timber, grazing, aesthetics, fish and wildlife, biodiversity, water quality, recreation, and other public benefits. Eligible Costs: The following costs are eligible for reimbursement: Future Projects – Due Diligence for Future Forest Legacy Project (a) The development and due diligence costs for future conservation easement or fee acquisition projects as stated above under Future Projects.
$50,000 – $150,000Official notice ↗ FederalDue in 11 days · Sep 30, 2026
Centers for Disease Control - NCEZID
This Notice of Funding Opportunity (NOFO) aims to support activities that build and strengthen sustainable fungal disease detection, diagnosis, surveillance, and response systems. Activities may address interconnected areas such as system and workforce development, laboratory and diagnostic capacity, and improved use of data to inform public health action. Through these efforts, this NOFO seeks to strengthen country and regional capacity to manage and control fungal diseases at their source while promoting long-term ownership and integration into public health systems. These efforts align with the priorities outlined in the America First Global Health Strategy by supporting country capacity to detect, respond to, and control priority fungal pathogens, particularly those that pose a risk for international spread and antifungal resistance, at their source. Over time, activities supported through this NOFO are intended to reduce the global burden of fungal diseases, strengthen health security, and help countries protect their own populations while also reducing risks to the United States through earlier detection and more effective response to fungal disease threats worldwide
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Department of Housing and Urban Development
The Continuum of Care (CoC) Program is designed to:promote a community-wide commitment to the goal of ending homelessness;provide funding for efforts by nonprofit providers, States, Indian Tribes or Tribally Designated Housing Entities [as defined in section 4 of the Native American Housing Assistance and Self-Determination Act of 1996 (25 U.S.C. 4103) (TDHEs)], and local governments to quickly rehouse individuals and families experiencing homelessness, persons experiencing trauma or a lack of safety related to, or fleeing or attempting to flee domestic violence, dating violence, sexual assault, and stalking, and youth experiencing homelessness while minimizing the trauma and dislocation caused by homelessness;promote access to, and effective utilization of, mainstream programs and programs funded with State or local resources; andoptimize self-sufficiency among individuals and families experiencing homelessness.The goal of the Youth Homelessness Demonstration Program (YHDP) is to support the development and implementation of a coordinated community approach to preventing and ending youth homelessness and sharing that experience with and mobilizing communities around the country toward the same end. The population to be served by the demonstration program is youth ages 24 and younger who are experiencing homelessness, including unaccompanied and pregnant or parenting youth.
$2,500 – $25,000,000Official notice ↗ FederalDue in 11 days · Sep 30, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Award supports collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and will significantly accelerate progress toward ending breast cancer. Applications must propose a synergistic, highly integrated, multidisciplinary and multi-institutional consortium of leading scientists, clinicians and breast cancer consumer advocates that will address a major problem in a way that a single investigator or group could not accomplish. The consortium’s collaborative efforts must make a transformative impact in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. If the application addresses a different fundamental issue, the application must couple it with at least one of the overarching challenges.
Distinctive Features: This funding mechanism allows for up to five Principal Investigators (PIs) which includes the Consortium Director and three or four Project Team PIs. Applications must include at least one breast cancer consumer advocate per project team. Only the Consortium Director will submit a pre-application, but all PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Consortium Director and Project Team PIs) applications by the full application deadline may result in administrative withdrawal.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Level 3.
Distinctive Features:
· For this funding mechanism, small-scale clinical trials are allowed but not required. Applications proposing projects with a clinical trial should be submitted under the Clinical Trial option.
· The research team must include two or more breast cancer consumer advocates.
· This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Pilot Clinical Trial Award (PCTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of amyotrophic lateral sclerosis (ALS). Projects may range from phase 1 to small-scale phase 2 trials.
Applications must address one of the following focus areas:
· Biomarker-Driven Interventions: Disease-modifying interventions, with mechanism-specific biomarkers to predict which clinical trial participants are likely to respond, demonstrate target engagement, and effects on the intended biological pathway.
· Clinical Care: Improving aspects of clinical care and symptom management for ALS.
Distinctive Features: Funding from this award mechanism must support a clinical trial. The clinical trial should begin no later than 12 months after the award date or 18 months for U.S. Food and Drug Administration (FDA)-regulated studies.
Projects proposing a therapeutic intervention (drug, biologic, and/or device) must incorporate biomarkers specific to the intervention into the trial design.
All pre-applications and applications are required to incorporate community collaboration, as described in Section 3.2.2, to optimize research impact.
Applications must include a detailed Regulatory Strategy plan that outlines the approach for obtaining regulatory approvals, if required, specifically for the funded portion of the study. In addition, applications must provide a separate Transition Plan that describes how the outcomes of the study will be advanced to the next phase of development, beyond the scope of the funded work.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Level 4.
Distinctive Features:
· Clinical trials are required.
· The research team must include two or more breast cancer consumer advocates.
· This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in amyotrophic lateral sclerosis (ALS). Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly apply to all patients.
Distinctive Features: To meet the intent of the funding opportunity, applications may address clinical biomarkers and/or clinical outcomes. This may include the identification, development, and/or validation of promising biomarkers for ALS, which may include, but are not limited to susceptibility/risk, diagnostic, monitoring/disease progression, prognostic, predictive, response, or safety biomarkers. Clinical Outcomes projects may focus on the identification, development, and/or validation of clinician-, observer-, or patient-reported, and/or performance outcome measures for ALS. Projects may include the optimization of current outcome measures already in use.
Applications may utilize digital health measures, including wearable devices, smart-phone sensors, video or voice recordings, imaging studies, or other devices which record disease-relevant physiological data and/or outcomes.
Community Collaboration is an important element of the FY26 ALSRP COBA. Applicants will be expected to articulate how the proposed research question or study design was informed by the
ALS lived experience community.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. The proposed studies are expected to be empirical in nature and product-driven. Applicants with limited amyotrophic lateral sclerosis (ALS) experience are strongly encouraged to include collaborators with substantial experience in the relevant ALS model systems, endpoints and pathophysiology.
Applications supported by this award must begin with lead compounds in hand and must already demonstrate proof-of-concept efficacy data in at least one appropriate preclinical model system of ALS, including whole-animal and cellular model systems.
Distinctive Features: Mechanism-specific, predictive/cohort-selective, target engagement and pharmacodynamic biomarker development, in parallel to the main therapeutic effort, is a critical component of the FY26 ALSRP Therapeutic Development Award. If appropriate mechanism-specific biomarkers are already available or currently in development, how the existing biomarkers will improve trial design, patient selection, and efficiency or interpretation of the proposed ALS therapeutic approach must be apparent in the application. Development of biomarkers for the purposes of diagnosis, prognosis, or measurement of general disease progression without consideration of the therapeutic development process will not be supported.
Therapeutic candidates which have already been granted an IND are not appropriate for this mechanism.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Assistance Coordination
The Middle East Regional Cooperation (MERC) Program supports joint scientific research and innovation partnerships between the United States, Israel, and countries across the Middle East and North Africa (MENA). The program funds applied research projects that address shared regional challenges while advancing U.S. economic, technological, and strategic interests. MERC is designed to bring together researchers, technical experts, and institutions to work on projects that go beyond basic research and demonstrate clear potential for application, commercialization, and broader adoption. MERC prioritizes efforts that strengthen U.S. technological leadership, expand opportunities for U.S. businesses, promote the use of U.S. technologies, and build long-term partnerships in the region. The program places strong emphasis on collaboration. All projects must include organizations from Israel and at least one eligible MENA country or territory. MERC welcomes U.S. participation, particularly when it adds technical expertise, supports market expansion for U.S. companies, or helps connect research to markets. Projects should demonstrate a clear plan for using and scaling results and how the outcomes benefit priorities of the United States and the participating countries. Overall, MERC aims to strengthen regional cooperation by supporting high-quality scientific partnerships that produce tangible results. By connecting U.S., Israeli, and MENA organizations, the program helps build networks, promote innovation, and create opportunities for economic growth, peaceful and mutually beneficial collaboration, and long-term stability in the region.
$100,000 – $2,000,000Official notice ↗ FederalDue in 11 days · Sep 30, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation.
Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Concept Award (CA) supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. Applications must describe how the new idea will be innovative and present as a novel course of investigation in the field of rare cancers.
Distinctive Features:
Preliminary data are not required.
Due to the blinded nature of the review process, identifying or making references to the Principal Investigator (PI), collaborator(s), or their organization(s) in the proposal Project Narrative, Supporting Documentations, Impact Statement, Justification Statement, and Statement of Work (SOW) is prohibited and will result in administrative rejection of the application.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications for Centers within the NIDDK Cooperative Centers of Experimental in Hematology (CCEH) Program. Each Center will support one to three Biomedical Research Cores and an Administrative Core, including an Enrichment Program. Each Center is expected to work collaboratively with NIDDK, the Hematology Coordinating Center (HCC), and the other CCEH Centers. The CCEH Program is designed to increase access to critical research resources and expertise unique to nonmalignant hematology research. By providing innovative technology, resources, and expertise to the greater hematology research community, the program will serve as a national hub, aimed at recruiting and retaining both junior scientists just beginning their careers in the field as well as established investigators from other domains.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
National Institutes of Health
This is a NOFO for a Single Source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is announcing its intent to issue a single source cooperative agreement award to Beckman Research Institute/City of Hope for the currently funded Integrated Islet Distribution Program (IIDP) to renew the program and maintain support for its continuing mission to provide the scientific community with important islet resources for diabetes research. The IIDP facilitates the distribution of human islets to biomedical researchers by establishing partnerships with qualified islet isolation facilities to prepare and distribute human islets. Human islets remain an essential resource for diabetes research to advance our understanding of human islet cell biology, and to promote the development of new therapies for the prevention and treatment of diabetes.This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.
FederalDue in 11 days · Sep 30, 2026
National Institutes of Health
This Notice of Funding Opportunity (NOFO) invites a single cooperative agreement application for the Resource Center for the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D). The purpose of CaRe-T1D is to support innovative, discovery and mechanistic research through the study of human cardiovascular (CV) tissue. This research seeks to better understand cardiovascular disease (CVD) in type 1 diabetes, highlight differences compared to type 2 diabetes, and ultimately guide the development of therapies to treat this major cause of morbidity and mortality for individuals with type 1 diabetes. To achieve these goals, the Resource Center will expand the CaRe-T1D biorepository of human CV tissue, further develop the data commons for data sharing and for artificial intelligence (AI) tools, coordinate the research activities of the investigative teams in the CaRe-T1D consortium, and make CaRe-T1D resources accessible to the broader research community. This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.
FederalDue in 11 days · Sep 30, 2026
Office of Science
The Office of Science (SC) of the Department of Energy (DOE) hereby announces its continuing interest in receiving applications for support of work in the following program areas: Advanced Scientific Computing Research, Basic Energy Sciences, Biological and Environmental Research, Fusion Energy Sciences, High Energy Physics, Nuclear Physics, and Isotope R&D and Production. On September 3, 1992, DOE published in the Federal Register the Office of Energy Research Financial Assistance Program (now called the Office of Science Financial Assistance Program), 10 CFR 605, as a Final Rule, which contained a solicitation for this program. Information about submission of applications, eligibility, limitations, evaluation and selection processes and other policies and procedures are specified in 10 CFR 605.
This NOFO is our annual open solicitation that covers all research areas in SC and is open throughout the Fiscal Year. Any research within SC’s Congressionally authorized mission may be proposed under this NOFO.
This NOFO will remain open until September 30, 2026, 11:59 PM Eastern Time, or until it is succeeded by another issuance, whichever occurs first. This NOFO succeeds DE-FOA-0003432, which was published September 30, 2024.
$50,000 – $5,000,000Official notice ↗ FederalDue in 11 days · Sep 30, 2026
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to establish a Center that trains researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics and to advance the best concepts through initial experiments via technical and financial support.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Bureau of Near Eastern Affairs
The Bureau of Near Eastern Affairs’ Office of Assistance Coordination (NEA/AC) of the U.S. Department of State announces an open competition for organizations to submit a statement of interest (SOI) for innovative foreign assistance programs benefitting partner countries that also advance U.S. commercial diplomacy and place American interests first. SOI must demonstrate how projects will leverage foreign assistance for U.S. partners as a tool of statecraft to advance U.S. economic, security, and diplomatic objectives. Programming should promote trade, not aid, by leveraging assistance resources to champion American enterprise and infrastructure and catalyze private capital through market principles.
$250,000 – $30,000,000Official notice ↗ FederalDue in 11 days · Sep 30, 2026
DARPA - Biological Technologies Office
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is soliciting proposals that leverage biological properties and processes to revolutionize our ability to protect the nation’s warfighters. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Office of Naval Research
ONR, ONRG, and MCWL are interested in receiving proposals for Long-Range S&T Projects that offer potential for advancement and improvement of Navy and Marine Corps operations. Readers should note that this is an announcement to declare ONR, ONRG and MCWL’s broad role in competitive funding of meritorious research across a spectrum of science and engineering disciplines.
All responsible sources from academia, industry and the research community worldwide may submit proposals under this BAA. All businesses, both small and large, are encouraged to submit proposals and compete for funding consideration.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Naval Research Laboratory
Amendment 0007
The purpose of this amendment is to add Summary Topic 61-24-06 - AFFF ALTERNATIVE PROGRAM COMPATIBILITY OF FLUORINE-FREE FOAM (F3) WITH NON-ASPIRATING SPRINKLER NOZZLES to Appendix 1 in it’s entirety. All other terms and conditions remain unchanged.
--------------------------------------------------------------
Amendment 0006
The purpose of this amendment is to extend the due date for acceptance of White Papers. All other terms and conditions remain unchanged.
--------------------------------------------------------------
Amendment 0005
The purpose of this amendment is to provide a searchable list of Summary Topics contained in Appendix 1. Expanded descriptions of each topic can be found in the full announcement pdf.
APPENDIX 1 – RESEARCH DESCRIPTION - SUMMARY TOPICS
II. Detailed information about the funding opportunity
The Naval Research Laboratory (NRL) is the Navy's corporate laboratory. NRL conducts basic and applied research for the Navy in a variety of scientific and technical disciplines. The basic research program is driven by perceptions about future requirements of the Navy.
The Navy's operational effectiveness depends on its ability to keep pace with rapidly developing technologies. NRL contributes to this requirement by conducting research in the following areas, organized into NRL'S three research directorates and Naval Center for Space Technology:
Systems Directorate Code 5000
Materials Science and Component Technology Directorate Code 6000 Ocean and Atmospheric Science and Technology Directorate Code 7000 Naval Center for Space Technology Code 8000
A. SYSTEMS DIRECTORATE - CODE 5000
53-24-01 - HIGH FREQUENCY RADAR
53-24-01C - HIGH FREQUENCY RADAR (CLASSIFIED)
53-24-02 - LOW-COST WIDEBAND ANTENNA ARRAY TECHNOLOGIES
53-24-03 - ADVANCED COMPUTATIONAL ELECTROMAGNETICS
55-24-01 - INFORMATION AND DECISION SCIENCES
55-24-02 - MATHEMATICAL FOUNDATIONS OF HIGH ASSURANCE COMPUTING
55-24-03 - HIGH ASSURANCE ENGINEERING AND COMPUTING
55-24-04 - ADVANCED NAVAL NETWORK SOLUTIONS
55-24-05 - FEDERATED, DISTRIBUTED COMPUTING/NETWORK INFRASTRUCTURE
56-24-01 - OPTICAL SCIENCES R&D
57-24-01 - ELECTROMAGNETIC TECHNIQUES AND TECHNOLOGY RESEARCH AND DEVELOPMENT
57-24-02 - SHIPBOARD ELECTRONIC WARFARE
B. MATERIALS SCIENCE AND COMPONENT TECHNOLOGY DIRECTORATE CODE 6000
60-24-01 - HIGH PERFORMANCE COMPUTING ON MASSIVELY PARALLEL ARCHITECTURES
61-24-01 - ELECTROCHEMICAL ENERGY STORAGE, CONVERSION AND COMMAND/CONTROL
61-24-02 - CORROSION PROCESSES, CONTROL, MITIGATION, AND TECHNOLOGY
61-24-03 - APPLICATIONS OF MOLECULAR BIOLOGY, BIOCHEMISTRY, ANALYTICAL CHEMISTRY AND ADVANCED LASER TECHNIQUES
61-24-04 - MULTIECHELON DIAGNOSTICS (MEDx) TECHNOLOGY DEVELOPMENT AND TIERED EVALUATION
63-24-01 - MATERIALS PERFORMANCE, PROCESSING, AND MODELING
67-24-01 - BASIC AND APPLIED RESEARCH IN PLASMA SCIENCE
68-24-01 - RADIATION EFFECTS RESEARCH
68-24-02 - PHOTOVOLTAICS FOR PORTABLE POWER
C. OCEAN AND ATMOSPHERIC SCIENCE AND TECHNOLOGY DIRECTORATE CODE 7000
71-24-01 - ACOUSTIC SIMULATION AND TACTICS
72-24-01 - LOW FREQUENCY RADIO INTERFEROMETRY
72-24-02 - OPTICAL REMOTE SENSING OF THE COASTAL REGIME
72-24-03 - REMOTE SENSORS AND IMAGING SYSTEMS
72-24-04 - AIRBORNE, SHIPBOARD, AND OVERHEAD DATA ACQUISITION AND ANALYSIS
73-24-01 - OCEAN DYNAMICS AND PREDICTION OCEANOGRAPHY
73-24-02 - SEAFLOOR SCIENCES
73-24-03 - GEOSPATIAL SCIENCES AND TECHNOLOGY
75-24-01 - ATMOSPHERIC EFFECTS, ANALYSIS, AND PREDICTION
76-24-01 - RESEARCH INTO SPACE, BACKGROUNDS, IMAGING AND MODELING
D. NAVAL CENTER FOR SPACE TECHNOLOGY CODE 8000
82-24-01 - SPACECRAFT & SPACE SYSTEMS TECHNOLOGY
--------------------------------------------------------------
Amendment 0004
The purpose of this amendment is to extend the due date for acceptance of White Papers and revise Appendix 1 Summary Topics and email addresses in it’s entirety.
--------------------------------------------------------------
Amendment 0003
The purpose of this amendment is to extend the due date for acceptance of White Papers. All other terms and conditions remain unchanged.
-------------------------------------------------------------
Amendment 0002
The purpose of this amendment is to extend the due date for acceptance of White Papers. All other terms and conditions remain unchanged.
-------------------------------------------------------------
Amendment 0001
The purpose of this amendment is to extend the due date for acceptance of White Papers. All other terms and conditions remain unchanged.
--------------------------------------------------------------
The Naval Research Laboratory is interested in receiving innovative proposals that offer potential for advancement and improvement in the technical topic areas listed. This notice constitutes a Broad Agency Announcement (BAA) as contemplated in FAR 6.302(d) that provides for the competitive selection of research proposals. The Government reserves the right to select for award all, some, or none of the propos…
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Sep 30, 2026
Idaho Field Office
Staff Support for Regional State Engagement with the United States (U.S.) Department of Energy, Office of Nuclear Energy, Office of Storage & Transportation on Radioactive Materials Transportation Planning. Facilitate engagement between DOE and State government representatives in four (4) specific regions (Eastern Region, Western Region, Midwestern Region, or Southern Region of the United States) and the Office of Storage & Transportation (DOE-S&T) in planning for future large-scale DOE transportation of commercial used nuclear fuel (UNF) and high-level radioactive waste (HLW), and addressing related DOE program issues that may impact a State or region. DOE anticipates making a total of four (4) awards e from this NOFO, one (1) award for each region.
FederalDue in 11 days · Sep 30, 2026
Idaho Field Office
Staff Support to the Tribal Radioactive Materials Transportation Committee for Engagement with the U.S. Department of Energy on Radioactive Materials Transportation Planning. Facilitate engagement between DOE and federally-recognized Tribal governments throughout the United States in planning for future large-scale DOE transportation of commercial used nuclear fuel (UNF), high-level radioactive waste (HLW) and other radioactive wastes, as well as related DOE program issues that may impact Tribal areas.